Trials & Filings

Alcobra Adult ADHD Drug Posts Good Results

Trial shows improvements in Test of Variables of Attention score

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Alcobra has posted highly statistically significant positive results from a Phase IIb clinical trial with MG01CI (Metadoxine extended-release) in adults with Predominantly Inattentive Attention Deficit Hyperactivity Disorder (PI-ADHD). The trial was a randomized, double-blind, placebo-controlled, cross-over single center study that enrolled 36 adult subjects with PI-ADHD at Geha Mental Health Center in Petach Tikva, Israel. Eligible subjects were randomly assigned in a 1:1:1 ratio to one of thr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters